北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (5): 756-759. doi: 10.3969/j.issn.1671-167X.2017.05.003

• 获奖工作综述 • 上一篇    下一篇

儿童晕厥诊断和治疗进展

徐文瑞1, 廖莹1, 金红芳1, 张清友1, 唐朝枢2, 杜军保1   

  1. 1. 北京大学第一医院儿科, 北京 100034;
    2. 北京大学基础医学院生理学与病理生理学系, 北京 100191
  • 收稿日期:2017-06-10 出版日期:2017-10-18 发布日期:2017-10-18
  • 基金资助:
    国家十二五科技支撑计划(2012BA103B03)、首都医学发展基金重点支持项目(2007-2003)、首都医学发展基金自主创新项目(2002-3037)、首都临床特色应用研究(Z121107001012051,D10100050010059)、首都十大危险疾病科技成果推广专项(Z11110006140000)及北京市科技计划课题(Z171100001017253)资助; 2007年教育部科技进步一等奖(儿童晕厥临床诊治的综合研究), 2007年宋庆龄儿科医学奖(儿童晕厥及其相关疾病的临床研究), 2014年华夏医学科技奖二等奖(提高儿童晕厥诊断和治疗水平的关键技术研究)

Progress in diagnosis and management of syncope in children

XU Wen-rui1, LIAO Ying1, JIN Hong-fang1, ZHANG Qing-you1, TANG Chao-shu2, DU Jun-bao1   

  1. 1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China;
    2. Department of Physiology and Pathophysiology, Peking University School of Basic Medical Sciences, Beijing 100191, China
  • Received:2017-06-10 Online:2017-10-18 Published:2017-10-18
  • Supported by:
    Supported by the National Twelfth Five-Year-Plan for Scientific and Technological Support Project(2012BA103B03), the Key Program of the Capital Foundation of Medical Developments (2007-2003), the Knowledge Innovation Program of the Capital Foundation of Medical Developments(2002-3037), the Capital Foundation for Clinical Characteristics and Application Research(Z121107001012051,D10100050010059), the Promotional Project of Scientific and Technological Achievements for the Ten Dangerous Diseases in Beijing(Z11110006140000) and the Beijing Science and Technology Plan (Z171100001017253); In 2007, the clinical diagnostic protocol for syncope in children gained the First Prize of Scientific and Technological Progress Award of Ministry of Education, China, and the research progress of syncope in children and the related diseases gained the Soong Ching Ling Foundation Pediatrics Award; In 2014, the research on the key technique of improving the diagnosis and management level of syncope in children gained the Second Prize of Huaxia Medical Science Award

关键词: 儿童晕厥, 诊断流程, 治疗

Abstract: SUMMARY Syncope is a common emergency of children and adolescents, which has serious influence on the quality of life. Neurally-mediated syncope, including postural tachycardia syndrome, vasovagal syncope, orthostatic hypotension and orthostatic hypertension, is the main cause of syncope in children and adolescents. The main manifestations of neurally-mediated syncope are diverse, such as dizziness, headache, chest tightness, chest pain, pale complexion, fatigue, pre-syncope and syncope. Although the clinical manifestations are similar, each subtype of syncope has its hemodynamic feature and optimal treatment option. The diagnosis rate of syncope in children has been greatly improved on account of the development of the diagnostic procedures and methods. In recent years, with the promotion of head-up tilt test and drug-provocated head-up tilt test, the hemodynamic classification of neurally-mediated syncope gets continually refined. In recent years, with the effort of clinicians, an appropriate diagnostic protocol for children with syncope has been established. The initial evaluation consists of history taking, physical examination, standing test and standard electrocardiography. After the initial evaluation, some patients could be diagnosed definitely, such as postural tachycardia syndrome, orthostatic hypotension, and situ-ational syncope. Those with a specific entity causing syncope need selective clinical and laboratory investi-gations. Patients for whom the cause of syncope remained undetermined should undergo head-up tilt test. The precise pathogenesis of neurally-mediated syncope is not entirely clear. In recent years, studies have shown that neurally-mediated syncope may be related to several factors, including hypovolemia, high catecholamine status, abnormal local vascular tension, decreased skeletal muscle pump activity and abnormal neurohumoral factors. Currently based on the possible pathogenesis, the individualized treatment of neurally-mediated syncope has also been studied in-depth. Generally, the management of neurally-mediated syncope includes non-pharmacological and pharmacological interventions. Patient education is the fundamental part above all. In addition to exercise training, the first-line treatments mainly include oral rehydration salts, beta adrenoreceptor blockers, and alpha adrenoreceptor agonists. By analyzing the patient’s physiological indexes and biomarkers before treatment, the efficacy of medication could be well predicted. The individualized treatment will become the main direction in the future researches.

Key words: Syncope, children, Diagnostic protocol, Therapy

中图分类号: 

  • R725.4
[1] 杨锦艳, 王成, 田宏, 等.儿童一过性意识丧失基础疾病谱分析[J].国际儿科学杂志, 2014, 41(2): 195-197, 201.
[2] 中华医学会儿科学分会心血管学组,《中华儿科杂志》编辑委员会,北京医学会儿科学分会心血管学组等.儿童晕厥诊断指南(2016年修订版)[J].中华儿科杂志, 2016, 54(4): 246-250.
[3] Chen L, Li X, Todd O, et a1. A clinical manifestation-based prediction of haemedynamicpottems of orthostatic intolerance in children:a multi-centre study[J]. Cardiol Young, 2014,24(4): 649-653.
[4] Chen L, Zhang Q, Ingrid S, et a1. Aetiology and clinical characteristics of syncope in Chinese children[J].Acta Paediatr, 2007, 96(10): 1505-1510.
[5] 杜军保, 李万镇. 基础直立倾斜试验对儿童不明原因晕厥的诊断研究[J]. 中华儿科杂志, 1997, 35(6): 309-312.
[6] 张清友, 杜军保, 李万镇. 舌下含化硝酸甘油直立倾斜试验对儿童不明原因晕厥的诊断研究[J]. 中华儿科杂志, 2004,42(5): 71.
[7] 张清友, 杜军保, 李万镇. 儿童体位性心动过速综合征的临床特征及随访研究[J]. 中华儿科杂志, 2005, 43(3): 165-169.
[8] 赵娟,杨锦艳,金红芳,等.儿童直立性高血压的临床特征[J].中华儿科杂志, 2012, 50(11): 839-842.
[9] 蔺婧, 王瑜丽, 张清友,等. 儿童青少年晕厥疾病谱近30年变化及卫生经济学分析单中心报告[J]. 中国实用儿科杂志, 2016, 31(5): 350-355.
[10] Zhang Q, Du J, Wang C, et al. The diagnostic protocol in children and adolescents with syncope: a multi-centre prospective study[J].Acta Paediatr, 2009, 98(5): 879-884.
[11] 金红芳, 杨锦艳, 李雪迎, 等. 改良Calgary评分在儿童心源性晕厥和血管迷走性晕厥鉴别诊断中的意义[J]. 中华儿科杂志, 2012, 50(2): 117-120.
[12] Zhang Q, Zhu L, Wang C, et al. Value of history taking in children and adolescents with cardiac syncope[J]. Cardiol Young, 2013, 23(1): 54-60.
[13] Numata T, Abe H, Nagatomo T, et a1. Successful treatment of malignant neurocardiogenic syncope with repeated tilt training program [J]. JpnCirc J, 2000, 64(5): 406-409.
[14] 鲁雯馨,杜军保.体位性心动过速综合征患儿自主神经功能评价与锻炼的研究进展[J].中华儿科杂志, 2015, 53(2): 149-152.
[15] Lu W, Yan H, Wu S, et al. Electrocardiography-derived predictors for therapeutic response to treatment in children with postural tachycardia syndrome[J].J Pediatr, 2016, 176: 128-133.
[16] Hampton JL, Parry SW,Kenny RA, et al. Lower 24 hour urinary sodium concentrations are associated with more severe symptoms in subjects with vasovagal syncope[J]. Heart, 2004, 90(6): 687-688.
[17] Chu W, Wan C, Wu L, et al. Oral rehydration salts: an effective choice for the treatment of children with vasovagal syncope[J]. Pediatr Cardiol, 2015, 36(4): 867-872.
[18] Zhang Q, Liao Y, Tang C, et al. Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome[J]. J Pe-diatr, 2012, 161(2): 281-284.
[19] Li H, Wang Y, Liu P, et al. Body mass index (BMI) is associa-ted with the therapeutic response to oral rehydration solution in children with postural tachycardia syndrome[J].Pediatr Cardiol, 2016, 37(7): 1313-1318.
[20] Liao Y, Chen S, Liu X, et al. Flow-mediated vasodilation and endothelium function in children with postural orthostatic tachycardia syndrome [J]. Am J Cardiol, 2010, 106(3): 378-382.
[21] Zhang Q, Du J, Li Y. Endothelial function in children with vasovagal syncope via color Doppler flow imaging[J]. Chin J Pract Pediatr, 2005, 20(8): 482-484.
[22] Zhang Q, Du J, Tang C. The efficacy of midodrine hydrochloride in the treatment of children withvasovagal syncope [J].J Pediatr,2006, 149(6): 777-780.
[23] Zhang F, Li X, Ochs T, et al. Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome [J]. J Am Coll Cardiol, 2012, 60(4): 315-320.
[24] Liao Y, Yang J, Zhang F, et al. Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome[J].Am J Cardiol, 2013, 112(6): 816-820.
[25] Yang J, Zhao J, Du S, et al. Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride[J]. J Pediatr, 2013, 163(4): 1169-1173.
[26] Zhao J, Tang C, Jin H, et al. Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children [J]. J Pediatr, 2014, 165(2): 290-294.
[27] Thieben M, Sandroni P, Sletten D, et al. Postural orthostatic tachycardia syndrome: Mayo clinic experience [J]. Mayo Clin Proc, 2007, 82(3): 308-313.
[28] 张凤文, 廖莹, 李雪迎, 等.儿童体位性心动过速综合征美托洛尔和盐酸米多君治疗118例报告[J].中华儿科杂志, 2011, 49(6): 428-432.
[29] 廖莹, 李雪迎, 张燕舞, 等.β受体阻断剂治疗血管迷走性晕厥的Meta分析[J]. 北京大学学报(医学版), 2008, 40(6): 603-609.
[30] Zhang Q, Chen X, Li J, et al. Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome[J]. J Transl Med, 2014,12(1): 249.
[31] Zhao J, Du S, Yang J, et al. Usefulness of plasma copeptin as a biomarker to predict the therapeutic effectiveness of metoprolol for postural tachycardia syndrome in children[J].Am J Cardiol, 2014, 114(4): 601-615.
[32] 中华医学会儿科学分会心血管学组,《中华儿科杂志》编辑委员会.儿童晕厥诊断指南[J].中华儿科杂志, 2009, 47(2): 99-101.
[1] 刘家骏, 刘国康, 朱玉虎. 免疫相关性重症肺炎1例[J]. 北京大学学报(医学版), 2024, 56(5): 932-937.
[2] 黄教悌,胡菁,韩博. 治疗相关神经内分泌前列腺癌机制研究与靶向治疗新进展[J]. 北京大学学报(医学版), 2024, 56(4): 557-561.
[3] 侯婉音,董捷. 腹膜透析患者获得性肾囊肿出血3例[J]. 北京大学学报(医学版), 2024, 56(3): 546-550.
[4] 李文菁,张保宙,李恒,赖良鹏,杜辉,孙宁,龚晓峰,李莹,王岩,武勇. 胫距跟融合治疗终末期踝和后足病变的中短期临床结果[J]. 北京大学学报(医学版), 2024, 56(2): 299-306.
[5] 冯琦琛,盖铄,王昌明,李选. 经同侧大隐静脉入路髂静脉成型及支架植入术在日间治疗模式中的应用[J]. 北京大学学报(医学版), 2024, 56(2): 322-325.
[6] 彭圣嘉,祁雨,孙丽杰,李丹,王新宇,韩江莉,陈宝霞,张媛. 传入压力反射衰竭合并低钠血症1例[J]. 北京大学学报(医学版), 2024, 56(2): 357-361.
[7] 陈晨,梁宇红. 复杂根管上颌磨牙的根管治疗3例[J]. 北京大学学报(医学版), 2024, 56(1): 190-195.
[8] 任晓萌,李凯一,李春蕾. 基于转录组测序探索口腔扁平苔藓局部激素治疗敏感性相关分子特征[J]. 北京大学学报(医学版), 2024, 56(1): 32-38.
[9] 张晗,秦亦瑄,韦帝远,韩劼. 牙周炎患者种植修复维护治疗依从性的影响因素[J]. 北京大学学报(医学版), 2024, 56(1): 39-44.
[10] 周颖,赵宁,黄竑远,李庆祥,郭传瑸,郭玉兴. 双层软组织缝合封闭技术在下颌骨中早期药物相关性颌骨骨坏死患者手术治疗中的应用[J]. 北京大学学报(医学版), 2024, 56(1): 51-56.
[11] 邹雪,白小娟,张丽卿. 艾拉莫德联合托法替布治疗难治性中重度类风湿关节炎的疗效[J]. 北京大学学报(医学版), 2023, 55(6): 1013-1021.
[12] 薛蔚,董樑,钱宏阳,费笑晨. 前列腺癌新辅助治疗与辅助治疗的现状及进展[J]. 北京大学学报(医学版), 2023, 55(5): 775-780.
[13] 邱敏,宗有龙,王滨帅,杨斌,徐楚潇,孙争辉,陆敏,赵磊,卢剑,刘承,田晓军,马潞林. 腹腔镜肾部分切除术治疗中高复杂程度肾肿瘤的效果[J]. 北京大学学报(医学版), 2023, 55(5): 833-837.
[14] 王明瑞,姬家祥,赖金惠,唐鑫伟,胡浩浦,王起,许克新,徐涛,胡浩. 肾绞痛的药物治疗选择: 一项中国泌尿外科医生用药的现况调查[J]. 北京大学学报(医学版), 2023, 55(5): 871-875.
[15] 姜海红,李小凡,王建六. 宫颈癌慢性放射性肠炎与肠道微生物的关系[J]. 北京大学学报(医学版), 2023, 55(4): 619-624.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!